Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Value of the CHA2DS2-VASc score and Fabry-specific score for predicting new-onset or recurrent stroke/TIA in Fabry disease patients without atrial fibrillation.

Liu D, Hu K, Schmidt M, Müntze J, Maniuc O, Gensler D, Oder D, Salinger T, Weidemann F, Ertl G, Frantz S, Wanner C, Nordbeck P.

Clin Res Cardiol. 2018 Dec;107(12):1111-1121. doi: 10.1007/s00392-018-1285-4. Epub 2018 May 24.

2.

CHADS2 and CHA2DS2-VASc Scores Predict the Risk of Ischemic Stroke Outcome in Patients with Interatrial Block without Atrial Fibrillation.

Wu JT, Wang SL, Chu YJ, Long DY, Dong JZ, Fan XW, Yang HT, Duan HY, Yan LJ, Qian P.

J Atheroscler Thromb. 2017 Feb 1;24(2):176-184. doi: 10.5551/jat.34900. Epub 2016 Jun 15.

3.

Prediction of stroke or TIA in patients without atrial fibrillation using CHADS2 and CHA2DS2-VASc scores.

Mitchell LB, Southern DA, Galbraith D, Ghali WA, Knudtson M, Wilton SB; APPROACH investigators.

Heart. 2014 Oct;100(19):1524-30. doi: 10.1136/heartjnl-2013-305303. Epub 2014 May 23.

PMID:
24860007
4.

Risk Stratification for Recurrence and Mortality in Embolic Stroke of Undetermined Source.

Ntaios G, Vemmos K, Lip GY, Koroboki E, Manios E, Vemmou A, Rodríguez-Campello A, Cuadrado-Godia E, Giralt-Steinhauer E, Arnao V, Caso V, Paciaroni M, Diez-Tejedor E, Fuentes B, Pérez Lucas J, Arauz A, Ameriso SF, Hawkes MA, Pertierra L, Gómez-Schneider M, Bandini F, Chavarria Cano B, Iglesias Mohedano AM, García Pastor A, Gil-Núñez A, Putaala J, Tatlisumak T, Barboza MA, Athanasakis G, Makaritsis K, Papavasileiou V.

Stroke. 2016 Sep;47(9):2278-85. doi: 10.1161/STROKEAHA.116.013713. Epub 2016 Aug 9.

PMID:
27507859
5.

The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.

Roldán V, Marín F, Manzano-Fernández S, Gallego P, Vílchez JA, Valdés M, Vicente V, Lip GY.

J Am Coll Cardiol. 2013 Dec 10;62(23):2199-204. doi: 10.1016/j.jacc.2013.08.1623. Epub 2013 Sep 18.

6.

CHA2DS2-VASc score as a predictor of long-term cardiac outcomes in elderly patients with or without atrial fibrillation.

Xing Y, Sun Y, Li H, Tang M, Huang W, Zhang K, Zhang D, Zhang D, Ma Q.

Clin Interv Aging. 2018 Mar 29;13:497-504. doi: 10.2147/CIA.S147916. eCollection 2018.

7.

Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.

Kornej J, Hindricks G, Kosiuk J, Arya A, Sommer P, Husser D, Rolf S, Richter S, Piorkowski C, Gaspar T, Lip GY, Bollmann A.

Circ Arrhythm Electrophysiol. 2013 Oct;6(5):868-74. doi: 10.1161/CIRCEP.113.000869. Epub 2013 Sep 18.

PMID:
24047706
8.

De novo Diagnosis of Fabry Disease among Italian Adults with Acute Ischemic Stroke or Transient Ischemic Attack.

Romani I, Borsini W, Nencini P, Morrone A, Ferri L, Frusconi S, Donadio VA, Liguori R, Donati MA, Falconi S, Pracucci G, Inzitari D.

J Stroke Cerebrovasc Dis. 2015 Nov;24(11):2588-95. doi: 10.1016/j.jstrokecerebrovasdis.2015.07.012. Epub 2015 Aug 19.

PMID:
26298600
9.

R2CHADS2 score and thromboembolic events after catheter ablation of atrial fibrillation in comparison with the CHA2DS2-VASc score.

Chao TF, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Liao JN, Chung FP, Hsieh MH, Chen SA.

Can J Cardiol. 2014 Apr;30(4):405-12. doi: 10.1016/j.cjca.2014.01.005. Epub 2014 Jan 13.

PMID:
24582725
10.

Neurological complications of Anderson-Fabry disease.

Tuttolomondo A, Pecoraro R, Simonetta I, Miceli S, Arnao V, Licata G, Pinto A.

Curr Pharm Des. 2013;19(33):6014-30. Review.

PMID:
23448452
11.

Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.

Melgaard L, Gorst-Rasmussen A, Lane DA, Rasmussen LH, Larsen TB, Lip GY.

JAMA. 2015 Sep 8;314(10):1030-8. doi: 10.1001/jama.2015.10725.

PMID:
26318604
12.

Atrial Fibrillation Diagnosis Timing, Ambulatory ECG Monitoring Utilization, and Risk of Recurrent Stroke.

Lip GY, Hunter TD, Quiroz ME, Ziegler PD, Turakhia MP.

Circ Cardiovasc Qual Outcomes. 2017 Jan;10(1). pii: e002864. doi: 10.1161/CIRCOUTCOMES.116.002864.

PMID:
28096204
13.

Long-Term Risk of Ischemic Stroke After the Cox-Maze III Procedure for Atrial Fibrillation.

Albåge A, Sartipy U, Kennebäck G, Johansson B, Scherstén H, Jidéus L; Swedish Arrhythmia Surgery Group.

Ann Thorac Surg. 2017 Aug;104(2):523-529. doi: 10.1016/j.athoracsur.2016.11.065. Epub 2017 Feb 24.

PMID:
28242081
14.

Mechanical dyssynchrony of the left atrium during sinus rhythm is associated with history of stroke in patients with atrial fibrillation.

Ciuffo L, Inoue YY, Tao S, Gucuk Ipek E, Balouch M, Lima JAC, Nazarian S, Spragg DD, Marine JE, Berger RD, Calkins H, Ashikaga H.

Eur Heart J Cardiovasc Imaging. 2018 Apr 1;19(4):433-441. doi: 10.1093/ehjci/jex156.

PMID:
29579200
15.

Incidence of ischemic stroke or transient ischemic attack in patients with multiple risk factors with or without atrial fibrillation: a retrospective cohort study.

Yuan Z, Makadia R, Ryan P, Yannicelli D, Nessel C, Sarich T.

Curr Med Res Opin. 2015;31(7):1257-66. doi: 10.1185/03007995.2015.1041469. Epub 2015 May 6.

PMID:
25877807
16.

Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack.

Li J, Liu J, Liu M, Zhang S, Hao Z, Zhang J, Zhang C.

Cochrane Database Syst Rev. 2015 Sep 8;(9):CD009938. doi: 10.1002/14651858.CD009938.pub2. Review.

PMID:
26346232
17.

Long-Term Stroke Risk Prediction in Patients With Atrial Fibrillation: Comparison of the ABC-Stroke and CHA2DS2-VASc Scores.

Rivera-Caravaca JM, Roldán V, Esteve-Pastor MA, Valdés M, Vicente V, Lip GYH, Marín F.

J Am Heart Assoc. 2017 Jul 20;6(7). pii: e006490. doi: 10.1161/JAHA.117.006490.

18.

The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.

Jacobs V, May HT, Bair TL, Crandall BG, Cutler M, Day JD, Weiss JP, Osborn JS, Muhlestein JB, Anderson JL, Mallender C, Bunch TJ.

Heart Rhythm. 2015 Apr;12(4):681-6. doi: 10.1016/j.hrthm.2014.12.034. Epub 2014 Dec 26.

PMID:
25546809
19.

The CHADS2 score predicts ischemic stroke in chronic heart failure patients without atrial fibrillation: comparison to other stroke risk scores.

Kondo T, Yamada T, Morita T, Furukawa Y, Tamaki S, Iwasaki Y, Kawasaki M, Kikuchi A, Kawai T, Takahashi S, Ishimi M, Hakui H, Ozaki T, Sato Y, Seo M, Sakata Y, Fukunami M.

Heart Vessels. 2017 Feb;32(2):193-200. doi: 10.1007/s00380-016-0861-7. Epub 2016 Jun 21.

PMID:
27325225
20.

The Population-Based Long-Term Impact of Anticoagulant and Antiplatelet Therapies in Low-Risk Patients With Atrial Fibrillation.

Golive A, May HT, Bair TL, Jacobs V, Crandall BG, Cutler MJ, Day JD, Mallender C, Osborn JS, Stevens SM, Weiss JP, Woller SC, Bunch TJ.

Am J Cardiol. 2017 Jul 1;120(1):75-82. doi: 10.1016/j.amjcard.2017.03.256. Epub 2017 Apr 12.

PMID:
28483209

Supplemental Content

Support Center